UCB
World’s Largest Collection of Deprioritised Pharma Compounds Opens to Researchers
December 08 by Pharma IQ NewsA collection of 68 deprioritised pharmaceutical compounds1 is being made available to academic researchers through a partnership between the Medical Research Council (MRC) and seven global drug comp...
Baxter, UCB, TRI-VIZOR and H.Essers Create World’s First Community for Orchestrated Horizontal Collaboration in Transport and Logistics or "Carpooling for Cargo".
May 17 by Pharma IQ NewsBrussels (May 16th, 2011) – UCB and Baxter, two global healthcare companies, will bundle their pharmaceutical supply chains in Eastern Europe together with TRI-VIZOR, a spin-off company from t...
Constructing an Integrated Chemical and Test Data Management System to Industrial Standards
April 26 by Reiner DiedenReiner Dieden PhD, Analyst and Physical Chemistry and Logistics Director from UCB, joins Pharma IQ to discuss the development of a Compound Management Facility at the University of Bonn. Pharma I...
Building a Compound Management Facility – The Integration Challenge
March 31 by Helen WinsorReiner Dieden PhD, Analyst and Physical Chemistry and Logistics Director from UCB, joins Helen Winsor Pharma IQ, to report on the development of a compound management facility at The University of B...
How to Avoid Common Pitfalls in Formulation
February 02 by Helen WinsorOutsourcing various elements of formulation work has obvious advantages, but there are also some common pitfalls. Martin Schubert, Formulation Group Leader at UCB, joins Helen Winsor from Pharma IQ,...
UCB Case Study: Open Innovation and Risk Sharing Partnerships – What are the Benefits and Practicalities?
January 13 by Pharmaceuticals & Biotechnology EditorAsthma Insights with Matthew Catley, UCB
April 29 by Matthew CatleyMatthew Catley, Head of Respiratory Pharmacology, UCB, provides some insights into asthma and COPD. Please give some background about your company. What is your role, and what does it entail? U...